Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model

Autor: Younghee Lee, Guang Wu, Dongbum Kim, Yong Sung Kim, Su In Lee, Hyung-Joo Kwon, Sangkyu Park, Ji-Hee Ha, Byoung Kwon Park, Jung Nam Kim, Han-Bum Park, Te Ha Kim, Avishekh Gautam
Rok vydání: 2016
Předmět:
0301 basic medicine
medicine.drug_class
Colorectal cancer
Peptide
Antibodies
Monoclonal
Humanized

Humanized antibody
Monoclonal antibody
Peptides
Cyclic

Mice
03 medical and health sciences
0302 clinical medicine
Cell Movement
TM4SF5
Cell Line
Tumor

peptide vaccine
Animals
Humans
Medicine
anti- metastatic effect
Cell Proliferation
chemistry.chemical_classification
biology
business.industry
Liver Neoplasms
Membrane Proteins
HCT116 Cells
medicine.disease
Xenograft Model Antitumor Assays
Virology
Gene Expression Regulation
Neoplastic

Treatment Outcome
030104 developmental biology
colon cancer
Oncology
chemistry
Immunization
monoclonal antibody
030220 oncology & carcinogenesis
Hepatocellular carcinoma
Colonic Neoplasms
Injections
Intravenous

Vaccines
Subunit

biology.protein
Peptide vaccine
Antibody
business
Research Paper
Zdroj: Oncotarget
ISSN: 1949-2553
DOI: 10.18632/oncotarget.13005
Popis: // Guang Wu 1, * , Dongbum Kim 1, * , Byoung Kwon Park 1 , Sangkyu Park 2 , Ji-Hee Ha 3 , Te Ha Kim 4 , Avishekh Gautam 4 , Jung Nam Kim 4 , Su In Lee 4 , Han-Bum Park 2 , Yong-Sung Kim 3 , Hyung-Joo Kwon 1, 4 , Younghee Lee 2 1 Center for Medical Science Research, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea 2 Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju 28644, Republic of Korea 3 Department of Molecular Science and Technology, Ajou University, Suwon 16499, Republic of Korea 4 Department of Microbiology, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea * These authors contributed equally to this work Correspondence to: Hyung-Joo Kwon, email: hjookwon@hallym.ac.kr Younghee Lee, email: yhl4177@cbnu.ac.kr Keywords: TM4SF5, peptide vaccine, monoclonal antibody, colon cancer, anti- metastatic effect Received: August 19, 2016 Accepted: October 19, 2016 Published: November 01, 2016 ABSTRACT Transmembrane 4 superfamily member 5 protein (TM4SF5) is a potential therapeutic target for hepatocellular carcinoma (HCC) and colon cancer. In a previous study, we demonstrated the prophylactic and therapeutic effects of a TM4SF5-specific peptide vaccine and monoclonal antibody in HCC and colon cancer in a mouse model. Here, we designed a cyclic peptide targeting TM4SF5. Cyclic peptide-specific antibodies were produced in mice after immunization with a complex of the peptide, CpG-DNA, and liposomes. Intravenous injection of the CT-26 mouse colon cancer cell line into mice induced tumors in the lung. Immunization with the peptide vaccine improved the survival rate and reduced the growth of lung tumors. We established a monoclonal antibody specific to the cyclic TM4SF5-based peptide and humanized the antibody sequence by complementarity determining region-grafting. The humanized antibody was reactive to the cyclic peptide and TM4SF5 protein. Treatment of CT-26 cells with the humanized antibody reduced cell motility in vitro . Furthermore, direct injection of the humanized anti-TM4SF5 antibody in vivo reduced growth of lung tumors in mouse metastasis model. Therefore, we conclude that the immunization with the cyclic peptide vaccine and injection of the TM4SF5-specifc humanized antibody have an anti-metastatic effect against colon cancer in mice. Importantly, the humanized antibody may serve as a starting platf
Databáze: OpenAIRE